on April 27, 2006
Published online before print April 27, 2006, doi: 10.1161/01.ATV.0000223865.64812.26
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 26, 2005
Accepted on February 2, 2006
Combination of In Vivo Angiopoietin-1 Gene Transfer and Autologous Bone Marrow Cell Implantation for Functional Therapeutic Angiogenesis
Koichi Kobayashi ;
From the Departments of Cardiology (K. Kobayashi, T.K., N.I., M.A., T. M.), Molecular Neurosurgery (M.M.), Vascular Surgery (K. Komori), and Neurosurgery (M.M., J.Y.), Nagoya University Graduate School of Medicine, Nagoya, Japan
* To whom correspondence should be addressed. E-mail: murohara{at}med.nagoya-u.ac.jp.
Objective--Autologous bone marrow mononuclear cell (BM-MNC) implantation into ischemic tissues promotes angiogenesis, but a large amount of marrow aspiration is required, which is a major clinical limitation. Angiopoietin-1 (Ang-1) is requisite for vascular maturation during angiogenesis. We examined the impacts of combinatorial Ang-1 gene transfer and low-dose autologous BM-MNC implantation on therapeutic angiogenesis in a rabbit model of hind limb ischemia.
Methods and Results--Rabbits were divided into 4 groups: phosphate-buffered saline (control), 500 µg Ang-1 plasmid (Ang-1), 1x106 autologous BM-MNCs (BMC), and Ang-1 plasmid plus BM-MNCs (combination). The Ang-1 group had a greater angiographic score and capillary density compared with the control (P<0.05), but the Ang-1 gene therapy alone did not improve transcutaneous oxygen pressure (TcO2) and skin ulcer score. However, the combination group showed a significant improvement in not only angiographic score and capillary density (P<0.05) but also TcO2 (P<0.05) and skin ulcer score. These efficacies were greater in the combination group compared with the BMC group.
Conclusions--This Ang-1 gene and BM-MNC combination therapy enhances not only quantitative but also qualitative angiogenesis in ischemic tissues. Moreover, the combination therapy will enable a reduction in the amount of BM aspiration required for significant therapeutic angiogenesis.
Key words: angiogenesis • angiopoietin-1 • bone marrow cells • vasculogenesis
This article has been cited by other articles:
 |
|
 |
|
  Y. Yamamoto, T. Matsuura, G. Narazaki, M. Sugitani, K. Tanaka, A. Maeda, G. Shiota, K. Sato, A. Yoshida, and I. Hisatome Synergistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemia Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1329 - H1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Foubert, G. Matrone, B. Souttou, C. Lere-Dean, V. Barateau, J. Plouet, S. Le Ricousse-Roussanne, B. I. Levy, J.-S. Silvestre, and G. Tobelem Coadministration of Endothelial and Smooth Muscle Progenitor Cells Enhances the Efficiency of Proangiogenic Cell-Based Therapy Circ. Res., September 26, 2008; 103(7): 751 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Cho, S.-H. Moon, S.-H. Lee, S.-W. Kang, J. Kim, J. M. Lim, H.-S. Kim, B.-S. Kim, and H. M. Chung Improvement of Postnatal Neovascularization by Human Embryonic Stem Cell-Derived Endothelial-Like Cell Transplantation in a Mouse Model of Hindlimb Ischemia Circulation, November 20, 2007; 116(21): 2409 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Cho, I.-K. Kim, S. H. Bhang, B. Joung, Y. J. Kim, K. J. Yoo, Y.-S. Yang, C. Y. Choi, and B.-S. Kim Combined therapy with human cord blood cell transplantation and basic fibroblast growth factor delivery for treatment of myocardial infarction Eur J Heart Fail, October 1, 2007; 9(10): 974 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ichihara, Y. Yamada, G. Ichihara, T. Nakajima, P. Li, T. Kondo, F. J. Gonzalez, and T. Murohara A Role for the Aryl Hydrocarbon Receptor in Regulation of Ischemia-Induced Angiogenesis Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1297 - 1304. [Abstract] [Full Text] [PDF]
|
|